E2F1 and Burkitt lymphoma: We also treated the EBV-positive Burkitt’s lymphoma (BL) Raji cells and EBV-negative BL41 cells with CAL-101 and we observed a suppression of E2F1 in Raji but with less effect in BL41 (Fig. 6f).